This study protocol was approved by the Research Ethics Board. Data from patients who completed the POHM study were collected, and historical controls were selected, matched in 2:1 ratio to POHM cases by age in deciles, American Society of Anesthesiology class, and procedure. Then, potentially matched controls between January 2010 and December 2012 were identified by Medical Records, and the actual control charts were selected by the RANDBETWEEN function in Microsoft Excel. The cost analysis was conducted by the hospital Finance Department as per the provincial protocols for case costing.

Outcomes were predefined and unchanged during the trial. We compared the rates of postoperative 30-day mortality, readmissions, ED visits, and the total costs between the groups.

We used descriptive statistics (mean [SD] or n [%]) to describe the preoperative and predischarge characteristics of participants. Furthermore, cases and controls were compared using descriptive statistics.

A total of 54 POHM patients (recruited between April 17, 2014 and August 31, 2015) and 107 control patients (January 2010 and December 2012) were eligible for this study. Table 1 shows the demographic characteristics and outcomes for the 2 groups. For one of the cases, an American Society of Anesthesiologists class 1, only one control was found. No 30-day postoperative mortality occurred in the controls or cases. The 30-day postoperative ED visits were 3.7% (2/54) and 7.5% (8/107) in the POHM group and controls, respectively. There were two 30-day postoperative readmissions among the controls and none among the POHM cases. Table 2 shows the direct, indirect, and total costs between the cases and controls. The average total costs were Can $5826.32 (SD 1418.89) for cases and Can $9198.58 (SD 1513.59) for controls.

This study shows that the 30-day readmission or ED visit rates were comparable, if not lower, between POHM and historical cohorts. Conversely, the costs were lower. Based on the current literature, for hip or knee replacements, one would expect 2%-5% postoperative complication or readmission rates [6,7]. In other words, 95%-98% of patients would be safe to be discharged when surgically ready. With the advances in surgical techniques, anesthetic management, and postoperative analgesia, we believe that earlier discharge after surgery is becoming more feasible and acceptable. As the technology evolves, the POHM infrastructure will be able to capitalize on more sophisticated monitoring, including the rapidly evolving “wearables.” The POHM solution is not expected to change complication rates but with reliable wireless connectivity, real-time interactions with patients are feasible. Such continuity of care would allow a clinician to determine when a patient could be managed at home, return to a nonindex hospital, or return to the index hospital expeditiously, thereby making earlier postsurgical discharge safer with better patient satisfaction.

Postoperative follow-up phone calls have been implemented in many centers. However, little evidence exists that follow-up phone calls by themselves reduce postdischarge readmission rates or ED visits [8-10]. Of various measures that mitigate postdischarge readmissions, continuity of care by physicians who treated patients prior to admission is the most important factor in reducing readmissions [11,12]. The model of care in this study supported the patient after discharge with a multidisciplinary team, including surgeons who had operated on patients. We believe that the model of care is a crucial element in supporting patients after discharge.

The results of this study were viewed by the hospital as an important finding and led our hospital to partner with the Ontario TeleHealth Network. The cost associated with the POHM technology (hardware and software) is expected to drop further in the future. In addition, the ability to scale up; to maintain updates, patient privacy, confidential data repository; to add other devices onto the system; and to negotiate pricing by bulk has increased the ease of application of POHM.

This study has some limitations. Retrospective historical data were used as controls but conducting a concurrently controlled study was not feasible. Because the sample size was small, we could not draw the statistical significance of differences in 30-day ED visits or readmissions, although a trend of higher rates in the control group was observed. There is potential of missing the 30-day returns in the control group if a patient did not return to our hospital or was readmitted at another hospital. Nevertheless, the trend being already higher in the control group would suggest that if there were a bias, it would have been an underdocumenting of the 30-day mortality, readmissions, or ED visits in the control group. In addition, the cost tracking over the 2 periods in the chart audit was based on the same provincial methodology and with a relatively stable inflation rate, we believe the true cost differences are reflected in our comparisons. The physician costs both in terms of consults, both in patients with longer length of stay and in patients with 30-day ED visits or readmissions, were not tracked. As alluded to earlier, 30-day ED visits or readmissions in the control group to nonindex hospitals were not tracked and their costs, therefore, are not included. Nevertheless, the bias would have been in favor of the control group.

In conclusion, we believe that POHM is a new paradigm of postacute care model for surgical recovery, providing better surgical access by further reducing the length of stay, 30-day ED visits by providing continuity of care and addressing patient concerns, and 30-day readmission rates by stratifying postdischarge management at home, at a nonindex hospital, or return to the index hospital.